Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus [NA]

View source ↗

Summary

A clinical trial is evaluating BosSTENT implantation to treat pulsatile tinnitus caused by venous sinus stenosis, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BosSTENT

Snippet

Sponsor: Sonorous NV, Inc | Conditions: Pulsatile Tinnitus, Venous Sinus Stenosis | NA | Status: RECRUITING